Showing results (71-80 of 288) with videos related to
Sort By:
Pageof 29
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2009
BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplantsPeter H O'Donnell, Kate Swanson, Michelle A Josephson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignanciesDavid A Rizzieri, Eric Feldman, John F Dipersio, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2004
Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignanciesTodd M Zimmerman, Helena Harlin, Olatoyosi M Odenike, et al.Leukemia Research|August 5, 2014
Genomic aberrations in myeloid sarcoma without blood or bone marrow involvement: characterization of formalin-fixed paraffin-embedded samples by chromosomal microarraysM Kamran Mirza, Madina Sukhanova, Friedrich Stölzel, et al.Leukemia Research|October 16, 2015
Targeting bone marrow lymphoid niches in acute lymphoblastic leukemiaGeoffrey L Uy, Yen-Michael S Hsu, Amy P Schmidt, et al.Leukemia & Lymphoma|October 14, 2009
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrenceKoen van Besien, Alexander Dew, Shang Lin, et al.Leukemia & Lymphoma|April 15, 2003
Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013Richard T Silver, Bercedis L Peterson, Ted P Szatrowski, et al.Leukemia & Lymphoma|September 6, 2007
Successful allogeneic transplantation of patients with suspected prior invasive mold infectionBrian T Hill, Lavayna Kondapalli, Andrew Artz, et al.Cancer Chemotherapy and Pharmacology|August 2, 2008
A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804Richard M Stone, Kathleen A Donohue, Wendy Stock, et al.Proceedings of the National Academy of Sciences of the United States of America|February 16, 2006
Gene expression changes associated with progression and response in chronic myeloid leukemiaJerald P Radich, Hongyue Dai, Mao Mao, et al.Pageof 29